The Column Group Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
23
- Investments
-
139
- Portfolio
-
30
- Exits
-
34
The Column Group General Information
Company Description
Founded in 2007, The Column Group is a venture capital firm based in San Francisco, California. The firm prefers to invest in healthcare, life sciences, oncology, drug discovery, and technology-based sectors in the United States. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.thecolumngroup.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 1 Letterman Drive, Building D
- Suite DM-900
- San Francisco, CA 94129
- United States
The Column Group Investments (139)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Hexagon Bio | 23-Oct-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| TriGemX Bio | 01-Oct-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Circle Pharma | 16-Sep-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Sentrin Therapeutics | 01-Sep-2026 | Biotechnology | Startup | |||
| InduPro | 12-Aug-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Nura Bio | 22-Jun-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Vasque Bio | 09-Jun-2026 | Biotechnology | Stealth | |||
| Cajal Therapeutics | 29-May-2026 | Drug Discovery | Clinical Trials - General | |||
| Tortugas Neuroscience | 16-Apr-2026 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Monimoi Therapeutics | 01-Jan-2026 | Early Stage VC | Drug Discovery | Startup |
The Column Group Exits (34)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Neurona Therapeutics | 02-Jun-2026 | Merger/Acquisition | |
| Eikon Therapeutics | 05-Feb-2026 | ||
| Velia | 27-Dec-2025 | ||
| Ribon Therapeutics | 05-Aug-2024 | ||
| Escient Pharmaceuticals | 30-May-2024 | ||
| Carmot Therapeutics | 26-Jan-2024 | ||
| Sagimet Biosciences | 14-Jul-2023 | ||
| Effector Therapeutics | 25-Aug-2021 | ||
| Tenaya Therapeutics | 30-Jul-2021 | IPO | |
| Constellation Pharmaceuticals | 15-Jul-2021 | Merger/Acquisition |
The Column Group Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
The Column Group Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
The Column Group Co-Investors (129)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 8 |
|
|
||
| Euclidean Capital |
|
|
|||
| Lux Capital |
|
|
|||
| Horizons Ventures |
|
|
|||
| RA Capital Management |
|
|
The Column Group FAQs
-
What is The Column Group?
Founded in 2007, The Column Group is a venture capital firm based in San Francisco, California.
-
When was The Column Group founded?
The Column Group was founded in 2007.
-
Where is The Column Group headquartered?
The Column Group is headquartered in San Francisco, CA.
-
What is The Column Group's total asset value?
The Column Group has around in total assets under management.
-
How many investments has The Column Group made?
The Column Group has made 139 investments.
-
What has The Column Group invested in?
The Column Group has made numerous investments in companies like Hexagon Bio, TriGemX Bio, and Circle Pharma within the Drug Discovery industry.
-
What has The Column Group invested in recently?
The Column Group's latest investment was on 23-Oct-2026 in Hexagon Bio, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
